Try our beta test site
1 study found for:    20080279
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia;   Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenic Purpura;   Immune Thrombocytopenia
Interventions: Drug: Romiplostim;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.